Embecta (EMBC) Shares Outstanding (2020 - 2026)
Embecta (EMBC) posted Shares Outstanding (Entity) of $59.3 million for Q1 2026, little changed sequentially from $59.2 million in Q4 2025, and up 1.72% YoY from $58.3 million in Q1 2025.
Embecta (EMBC) Shares Outstanding (2020 - 2026) Analysis & Trends
Embecta has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $59.3 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 1.72% year-over-year to $59.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.3 million (up 1.72% YoY) and the FY2025 annual result came in at $58.5 million, up 1.37% from the prior year.
- Shares Outstanding (Entity) held at $59.3 million in Q1 2026 per EMBC's latest filing, from $59.2 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $59.3 million in Q1 2026 and troughed at $57.1 million in Q3 2022.
- A 5-year average of $57.9 million and a median of $57.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) slipped 0.88% in 2023, then rose 1.86% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $57.2 million in 2022, then gained by 0.63% to $57.6 million in 2023, then climbed by 0.97% to $58.1 million in 2024, then advanced by 1.86% to $59.2 million in 2025, then climbed by 0.2% to $59.3 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $59.3 million, $59.2 million, and $58.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.31 Bn | 129.09 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.51 Bn | 51.64 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.75 Bn | 34.40 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.70 Bn | 32.23 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.09 Bn | 26.41 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.03 Bn | 24.60 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.40 Bn | 14.99 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.81 Bn | 14.68 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.57 Bn | 11.42 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 58.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.48 Mn |
| Mar 31, 2026 | 59.30 Mn |
| Dec 31, 2025 | 58.80 Mn |
| Sep 30, 2025 | 58.31 Mn |
| Jun 30, 2025 | 58.49 Mn |
| Mar 31, 2025 | 58.29 Mn |
| Dec 31, 2024 | 57.95 Mn |
| Sep 30, 2024 | 57.68 Mn |
| Jun 30, 2024 | 57.77 Mn |
| Mar 31, 2024 | 57.69 Mn |
| Dec 31, 2023 | 57.49 Mn |
| Sep 30, 2023 | 57.25 Mn |
| Jun 30, 2023 | 57.30 Mn |
| Mar 31, 2023 | 57.26 Mn |
| Dec 31, 2022 | 57.11 Mn |
| Sep 30, 2022 | 57.02 Mn |
| Jun 30, 2022 | 57.80 Mn |
| Mar 31, 2022 | 57.80 Mn |
| Dec 31, 2021 | 57.01 Mn |
| Sep 30, 2021 | 57.01 Mn |